Laboratory Testing for Hepatocellular Liver Enzyme Elevation

Initial Core Laboratory Panel

The British Society of Gastroenterology recommends a standardized core panel as the first-line investigation for hepatocellular enzyme elevation, including viral hepatitis serologies, autoimmune markers, iron studies, and metabolic parameters 1, 2
Viral hepatitis serologies, including HBsAg, hepatitis B core IgM, and HCV antibody, are used to identify viral causes 1, 3
Autoimmune markers, such as serum IgG and autoantibodies, are used to detect autoimmune hepatitis 1
Iron studies, including ferritin and transferrin saturation, are used to evaluate for hemochromatosis, with a transferrin saturation >45% suggesting hemochromatosis 1
Metabolic parameters, including fasting glucose, lipid panel, and assessment for metabolic syndrome components, are used to evaluate for nonalcoholic fatty liver disease 3

For marked elevations (ALT >1000 U/L), consider additional viral serologies, including hepatitis A, hepatitis E, and cytomegalovirus 1
Extended testing, including thyroid function tests, creatine kinase, and ceruloplasmin and 24-hour urinary copper, may be reserved for patients without a clear cause after core panel 1, 3, 4

The goal of laboratory testing is etiologic diagnosis, not monitoring alone, as 84% of abnormal tests remain elevated at 1 month and 75% at 2 years 1, 2
Pattern recognition, including AST:ALT ratio, can suggest underlying causes, such as NAFLD, viral hepatitis, or alcoholic liver disease 3
Isolated elevated ferritin does not indicate hemochromatosis, and transferrin saturation >45% is required for diagnosis 1

Obtain specific details on alcohol consumption, medication use, metabolic syndrome features, risk factors for viral hepatitis, and symptoms 1, 2, 3

Abdominal ultrasound with Doppler is the initial imaging modality of choice for hepatocellular enzyme elevation, with a sensitivity of 84.8% and specificity of 93.6% for detecting moderate to severe hepatic steatosis 3, 4, 5
CT abdomen/pelvis with IV contrast may be considered for moderate to severe elevations 4, 5

Immediate specialist referral is warranted for unexplained clinical jaundice, suspicion of hepatic or biliary malignancy, or evidence of hepatitis B, HCV, autoimmune hepatitis, or hemochromatosis 1, 3, 4
Consider hepatology referral if transaminases remain elevated for ≥6 months without identified cause or if there is evidence of synthetic dysfunction 3